Midgard Science

Northway Biologics

Cambridge, MA, United States northwaybiotech.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Northway Biotech is a CDMO supporting biologics and advanced therapies from early development through cGMP manufacturing. It works with clients in mammalian, microbial, plasmid DNA, viral vector, and cell therapy programs from sites in Vilnius, Lithuania and Waltham/Boston, USA.

Services

  • Cell Line & Strain Development

    Develops high-producing mammalian cell lines and optimized microbial expression systems.

    Cell line development

  • Process Development (USP & DSP)

    Develops and optimizes upstream and downstream processes for scalable manufacturing and technology transfer.

  • Analytical Development

    Develops, qualifies, and validates phase-appropriate analytical methods.

  • cGMP Manufacturing

    Provides cGMP drug substance and drug product manufacturing for clinical and commercial supply.

    CDMO: development & manufacturing

  • Viral Clearance Studies

    Performs early and late-phase viral clearance studies to support purification process validation.

  • Quality & Regulatory CMC Support

    Provides integrated QA, QC, and CMC regulatory support from development through commercialization.

  • Mammalian Biologics Development & Manufacturing

    Supports mammalian programs including monoclonal antibodies, bispecific and multispecific antibodies, fusion proteins, and recombinant proteins.

    CDMO: development & manufacturing

  • Microbial Biologics Development & Manufacturing

    Supports bacterial and yeast expression systems for recombinant proteins and other microbial-derived biologics.

    CDMO: development & manufacturing

3 more services
  • pDNA Development & Manufacturing
  • Viral Vector Development & Manufacturing
  • Cell Therapy Development & Manufacturing

Capabilities

Assays and studies
  • Process development
  • Cell therapy
  • Analytical development
  • Bioreactors
  • Antibodies
  • CHO
9 more
  • Insect cells
  • Bispecifics
  • Analytical method development
  • Method qualification
  • Method validation
  • Viral clearance studies
  • Process characterization
  • Process validation
  • Purification process validation
Scale and capacity
  • 10 L to 4,000 L working volume mammalian manufacturing lines
  • Up to 3,000 L working volume microbial manufacturing
  • Up to 1,000 L working volume viral vector manufacturing
  • Up to 300 L working volume pDNA manufacturing
  • Up to 200 L working volume BSL-3 production capability
  • 3 fill & finish lines
Therapeutic areas
  • Biologics
  • Gene therapy
  • Cell therapy
  • Advanced therapies

Instruments and platforms

  • BSL-2 laboratories
  • BSL-3 laboratory
  • Single-use bioreactors
  • 3D bioprinting capabilities

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Viral vector
  • Cell therapy
  • Recombinant protein
  • Plasmid DNA
Species and models
  • CHO
  • E. coli
  • Bacteria
  • Yeast
  • Insect cell (S2)

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Company

Type
CDMO
Founded
2004
Size
51-200 employees

Locations

Based in
Cambridge, MA, United States
Sites
  • Vilnius, Lithuania
  • Waltham/Boston, USA
Serves
Europe, US, worldwide

Public records

Wikidata
Q25499288 source

Similar labs